KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
US$94,82
arrow_upward
+0,63%(+0,59) 1D
17 ພ.ຈ., 13 ໂມງ 31 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
US$94,23
High
US$95,70
Low
US$93,28
Mkt. cap
7,45 ຕື້
Avg. vol.
824,27 ພັນ
Volume
147,23 ພັນ
P/E ratio
72,38
52-wk high
US$99,31
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
Open
US$94,23
High
US$95,70
Low
US$93,28
Mkt. cap
7,45 ຕື້
Avg. vol.
824,27 ພັນ
Volume
147,23 ພັນ
P/E ratio
72,38
52-wk high
US$99,31
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
News stories
From web sources and news partners
GuruFocus
·
2 ຊົ່ວໂມງກ່ອນ
KNSA Maintained by TD Cowen -- Price Target Raised to $115
Investing.com UK
·
4 ຊົ່ວໂມງກ່ອນ
TD Cowen raises Kiniksa stock price target to $115 on Arcalyst growth
TradingView
·
1 ມື້ກ່ອນ
KNSA: ARCALYST growth and a H2 2027 KPL-387 readout anchor the outlook
Investing.com Canada
·
1 ມື້ກ່ອນ
Kiniksa at Jefferies Global Healthcare Conference: arcalyst growth rolls on By Investing.com
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquartersລອນດອນ, ປະເທດອັງກິດ, ສະຫະລາດຊະອະນາຈັກ
SectorHealth Care
IndustryBiotechnology
Websitekiniksa.com